🇬🇧 🇫🇷
A

Ambiopharm - A Global Peptide Cdmo

Pharmaceutical Manufacturing · United States · 1,000 employees

Pharmaceutical Manufacturing United States B2B Est. 2005
8 Decision makers
+1 New (6 months)
1,000 Employees
$65M Revenue
2005 Founded

Organizational Chart of Ambiopharm - A Global Peptide Cdmo

Roles identified within Ambiopharm - A Global Peptide Cdmo's leadership team, from public professional data, updated 18 Oct 2026.

Department

Ambiopharm - A Global Peptide Cdmo's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People

Decision makers at Ambiopharm - A Global Peptide Cdmo by function

General management

Sales

Other functions

See all Ambiopharm - A Global Peptide Cdmo contacts on Zeliq

Decision makers at Ambiopharm - A Global Peptide Cdmo

8 identified 2 VP 6 Directors +1 new (6 months)
See them on Zeliq →

Funding and news at Ambiopharm - A Global Peptide Cdmo

Funding

Last round Private equity
Total funding $24M (2 rounds)
Venture Round $24M Nov 2014
Private Equity Round N/A Sep 2018

Team Structure headcount by department

Research
37
Operations
20
Technical
11
Project Management
7
Finance
6
General Management
6
HR
6
Other
6

How to prospect Ambiopharm - A Global Peptide Cdmo's departments
Research

The company's largest department, with 37 people. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Operations

With 20 people, this is the organisation's second pillar. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Technical

11 people work in this department. Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

Project Management

A team of 7 people. These profiles own delivery: anything that de-risks a milestone gets their attention.

Finance

This department counts 6 people. Timing matters here: approach them around budget planning cycles, when arbitrations are actually open.

General Management

6 people work in this department. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Try the Zeliq email finder demo →

FAQ Ambiopharm - A Global Peptide Cdmo

Who runs Ambiopharm - A Global Peptide Cdmo?

The highest-ranking leadership role identified at Ambiopharm - A Global Peptide Cdmo is “Vice President of Manufacturing”, based on public data updated 18 Oct 2026.

How many decision makers does Ambiopharm - A Global Peptide Cdmo have?

8 decision makers identified.

How do I contact a decision maker at Ambiopharm - A Global Peptide Cdmo?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Ambiopharm - A Global Peptide Cdmo

More companies to explore

Pharmaceutical Manufacturing · United States

All Pharmaceutical Manufacturing companies in United States →

About Ambiopharm - A Global Peptide Cdmo

Ambiopharm - A Global Peptide Cdmo is a company active in the Pharmaceutical Manufacturing space, operating from United States. Founded in 2005, the company has a workforce of roughly 1,000 people. Ambiopharm - A Global Peptide Cdmo belongs to the Manufacturing sector, with a specific positioning on Pharmaceutical Manufacturing. Its customer base is mainly professional: Ambiopharm - A Global Peptide Cdmo operates on a B2B model. The company has secured 2 rounds of funding totalling $24M. Annual revenue is estimated at around $65M. The data below (industry, headcount, location and business signals) helps sales teams qualify Ambiopharm - A Global Peptide Cdmo and pinpoint the right decision makers from the first touchpoint.

Activity & Market

The company evolves in the Pharmaceutical Manufacturing segment of the Manufacturing sector. As a B2B company, Ambiopharm - A Global Peptide Cdmo primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.